Utah Medical Products, Inc. (UTMD)
USD 62.0
(-0.85%)
USD 62.0
(-0.85%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 16.77 Million USD | 45.08% |
| 2022 | 12.7 Million USD | -32.69% |
| 2021 | 18.88 Million USD | 190.51% |
| 2020 | 6.49 Million USD | -39.55% |
| 2019 | 10.75 Million USD | -42.5% |
| 2018 | 18.69 Million USD | -1.65% |
| 2017 | 19.01 Million USD | 17.45% |
| 2016 | 16.18 Million USD | 3.42% |
| 2015 | 15.65 Million USD | -3.4% |
| 2014 | 16.2 Million USD | 9.27% |
| 2013 | 14.82 Million USD | -2.42% |
| 2012 | 15.19 Million USD | 28.32% |
| 2011 | 11.84 Million USD | 32.73% |
| 2010 | 8.92 Million USD | -5.41% |
| 2009 | 9.43 Million USD | -9.21% |
| 2008 | 10.38 Million USD | -3.41% |
| 2007 | 10.75 Million USD | -0.73% |
| 2006 | 10.83 Million USD | 17.3% |
| 2005 | 9.23 Million USD | -8.63% |
| 2004 | 10.1 Million USD | -5.72% |
| 2003 | 10.72 Million USD | 1.71% |
| 2002 | 10.54 Million USD | 13.62% |
| 2001 | 9.27 Million USD | 10.89% |
| 2000 | 8.36 Million USD | 1.03% |
| 1999 | 8.28 Million USD | 23.61% |
| 1998 | 6.7 Million USD | 21.82% |
| 1997 | 5.5 Million USD | -53.78% |
| 1996 | 11.9 Million USD | 1.71% |
| 1995 | 11.7 Million USD | 17.0% |
| 1994 | 10 Million USD | 12.36% |
| 1993 | 8.9 Million USD | -5.32% |
| 1992 | 9.4 Million USD | 17.5% |
| 1991 | 8 Million USD | 33.33% |
| 1990 | 6 Million USD | 53.85% |
| 1989 | 3.9 Million USD | 95.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 3.34 Million USD | -2.76% |
| 2024 Q2 | 3.43 Million USD | -11.46% |
| 2024 Q1 | 3.88 Million USD | -1.55% |
| 2023 Q2 | 4.42 Million USD | 65.42% |
| 2023 FY | 18.43 Million USD | 45.08% |
| 2023 Q3 | 3.96 Million USD | -10.31% |
| 2023 Q4 | 3.94 Million USD | -0.63% |
| 2023 Q1 | 2.67 Million USD | -19.38% |
| 2022 FY | 12.7 Million USD | -32.69% |
| 2022 Q1 | 4.52 Million USD | -11.83% |
| 2022 Q4 | 3.31 Million USD | -2.3% |
| 2022 Q2 | 5.05 Million USD | 11.83% |
| 2022 Q3 | 3.39 Million USD | -32.85% |
| 2021 Q1 | 3.88 Million USD | -9.18% |
| 2021 FY | 18.88 Million USD | 190.51% |
| 2021 Q4 | 5.12 Million USD | 0.61% |
| 2021 Q3 | 5.09 Million USD | 6.99% |
| 2021 Q2 | 4.76 Million USD | 22.59% |
| 2020 FY | 6.49 Million USD | -39.55% |
| 2020 Q1 | 3.86 Million USD | -17.44% |
| 2020 Q3 | 3.58 Million USD | 81.49% |
| 2020 Q4 | 4.28 Million USD | 19.29% |
| 2020 Q2 | 1.97 Million USD | -48.82% |
| 2019 Q4 | 4.67 Million USD | 7.05% |
| 2019 Q1 | 4.1 Million USD | -3.91% |
| 2019 FY | 10.75 Million USD | -42.5% |
| 2019 Q2 | 4.48 Million USD | 9.24% |
| 2019 Q3 | 4.37 Million USD | -2.45% |
| 2018 FY | 18.69 Million USD | -1.65% |
| 2018 Q1 | 4.97 Million USD | 8.7% |
| 2018 Q3 | 4.4 Million USD | -12.94% |
| 2018 Q4 | 4.26 Million USD | -3.02% |
| 2018 Q2 | 5.05 Million USD | 1.71% |
| 2017 Q4 | 4.57 Million USD | -2.27% |
| 2017 Q2 | 5.03 Million USD | 6.54% |
| 2017 FY | 19.01 Million USD | 17.45% |
| 2017 Q1 | 4.72 Million USD | 30.49% |
| 2017 Q3 | 4.67 Million USD | -7.05% |
| 2016 FY | 16.18 Million USD | 3.42% |
| 2016 Q1 | 4.31 Million USD | 13.29% |
| 2016 Q2 | 4.31 Million USD | 0.07% |
| 2016 Q3 | 3.93 Million USD | -8.71% |
| 2016 Q4 | 3.62 Million USD | -8.07% |
| 2015 Q3 | 4 Million USD | 0.83% |
| 2015 FY | 15.65 Million USD | -3.4% |
| 2015 Q2 | 3.96 Million USD | 2.32% |
| 2015 Q1 | 3.87 Million USD | -9.73% |
| 2015 Q4 | 3.8 Million USD | -4.85% |
| 2014 Q2 | 4.06 Million USD | 5.7% |
| 2014 Q4 | 4.29 Million USD | 7.32% |
| 2014 FY | 16.2 Million USD | 9.27% |
| 2014 Q3 | 4 Million USD | -1.48% |
| 2014 Q1 | 3.84 Million USD | 7.98% |
| 2013 Q1 | 3.88 Million USD | 8.97% |
| 2013 FY | 14.82 Million USD | -2.42% |
| 2013 Q2 | 3.71 Million USD | -4.47% |
| 2013 Q3 | 3.66 Million USD | -1.35% |
| 2013 Q4 | 3.55 Million USD | -2.89% |
| 2012 Q1 | 4.11 Million USD | 41.26% |
| 2012 FY | 15.19 Million USD | 28.32% |
| 2012 Q3 | 3.96 Million USD | 11.49% |
| 2012 Q2 | 3.55 Million USD | -13.68% |
| 2012 Q4 | 3.56 Million USD | -9.87% |
| 2011 Q1 | 2.15 Million USD | -1.05% |
| 2011 Q4 | 2.91 Million USD | -17.69% |
| 2011 Q2 | 3.23 Million USD | 49.81% |
| 2011 Q3 | 3.53 Million USD | 9.46% |
| 2011 FY | 11.84 Million USD | 32.73% |
| 2010 FY | 8.92 Million USD | -5.41% |
| 2010 Q4 | 2.18 Million USD | -3.37% |
| 2010 Q3 | 2.25 Million USD | 2.82% |
| 2010 Q2 | 2.19 Million USD | -4.11% |
| 2010 Q1 | 2.28 Million USD | -3.66% |
| 2009 Q4 | 2.37 Million USD | -0.34% |
| 2009 FY | 9.43 Million USD | -9.21% |
| 2009 Q3 | 2.38 Million USD | 7.73% |
| 2009 Q2 | 2.21 Million USD | -10.0% |
| 2009 Q1 | 2.45 Million USD | 11.22% |
| 2008 Q1 | 2.54 Million USD | -3.35% |
| 2008 Q3 | 2.94 Million USD | 8.97% |
| 2008 Q4 | 2.21 Million USD | -24.8% |
| 2008 FY | 10.38 Million USD | -3.41% |
| 2008 Q2 | 2.69 Million USD | 6.22% |
| 2007 FY | 10.75 Million USD | -0.73% |
| 2007 Q4 | 2.62 Million USD | -3.38% |
| 2007 Q3 | 2.72 Million USD | 0.11% |
| 2007 Q2 | 2.71 Million USD | 0.97% |
| 2007 Q1 | 2.69 Million USD | -6.3% |
| 2006 FY | 10.83 Million USD | 17.3% |
| 2006 Q1 | 2.63 Million USD | 20.96% |
| 2006 Q2 | 2.59 Million USD | -1.41% |
| 2006 Q4 | 2.87 Million USD | 4.97% |
| 2006 Q3 | 2.73 Million USD | 5.43% |
| 2005 FY | 9.23 Million USD | -8.63% |
| 2005 Q4 | 2.17 Million USD | 6.77% |
| 2005 Q3 | 2.03 Million USD | -17.52% |
| 2005 Q2 | 2.47 Million USD | -3.17% |
| 2005 Q1 | 2.55 Million USD | 11.44% |
| 2004 Q2 | 2.62 Million USD | -0.08% |
| 2004 Q3 | 2.56 Million USD | -2.55% |
| 2004 Q4 | 2.29 Million USD | -10.58% |
| 2004 FY | 10.1 Million USD | -5.72% |
| 2004 Q1 | 2.63 Million USD | 1.08% |
| 2003 Q2 | 2.71 Million USD | 0.0% |
| 2003 Q4 | 2.6 Million USD | -3.49% |
| 2003 FY | 10.72 Million USD | 1.71% |
| 2003 Q1 | 2.71 Million USD | 2.57% |
| 2003 Q3 | 2.69 Million USD | -0.59% |
| 2002 FY | 10.54 Million USD | 13.62% |
| 2002 Q1 | 2.52 Million USD | -45.98% |
| 2002 Q2 | 2.6 Million USD | 3.21% |
| 2002 Q3 | 2.77 Million USD | 6.65% |
| 2002 Q4 | 2.64 Million USD | -4.72% |
| 2001 Q2 | 2.35 Million USD | 5.66% |
| 2001 Q3 | 2.39 Million USD | 1.87% |
| 2001 Q4 | 4.66 Million USD | 94.86% |
| 2001 FY | 9.27 Million USD | 10.89% |
| 2001 Q1 | 2.22 Million USD | 0.77% |
| 2000 Q2 | 2.12 Million USD | 13.31% |
| 2000 Q3 | 2.15 Million USD | 1.13% |
| 2000 Q4 | 2.2 Million USD | 2.6% |
| 2000 Q1 | 1.87 Million USD | -17.7% |
| 2000 FY | 8.36 Million USD | 1.03% |
| 1999 Q2 | 2 Million USD | 11.11% |
| 1999 Q3 | 2.2 Million USD | 10.0% |
| 1999 Q4 | 2.28 Million USD | 3.73% |
| 1999 Q1 | 1.8 Million USD | -10.0% |
| 1999 FY | 8.28 Million USD | 23.61% |
| 1998 Q4 | 2 Million USD | 5.26% |
| 1998 FY | 6.7 Million USD | 21.82% |
| 1998 Q1 | 1.4 Million USD | -12.5% |
| 1998 Q2 | 1.5 Million USD | 7.14% |
| 1998 Q3 | 1.9 Million USD | 26.67% |
| 1997 Q2 | 1.1 Million USD | 0.0% |
| 1997 Q4 | 1.6 Million USD | -5.88% |
| 1997 Q3 | 1.7 Million USD | 54.55% |
| 1997 FY | 5.5 Million USD | -53.78% |
| 1997 Q1 | 1.1 Million USD | -62.07% |
| 1996 FY | 11.9 Million USD | 1.71% |
| 1996 Q4 | 2.9 Million USD | -12.12% |
| 1996 Q3 | 3.3 Million USD | 6.45% |
| 1996 Q2 | 3.1 Million USD | 10.71% |
| 1996 Q1 | 2.8 Million USD | -9.68% |
| 1995 Q1 | 2.6 Million USD | 4.0% |
| 1995 Q2 | 2.9 Million USD | 11.54% |
| 1995 FY | 11.7 Million USD | 17.0% |
| 1995 Q4 | 3.1 Million USD | 3.33% |
| 1995 Q3 | 3 Million USD | 3.45% |
| 1994 Q1 | 2.4 Million USD | 50.0% |
| 1994 FY | 10 Million USD | 12.36% |
| 1994 Q4 | 2.5 Million USD | -3.85% |
| 1994 Q3 | 2.6 Million USD | 4.0% |
| 1994 Q2 | 2.5 Million USD | 4.17% |
| 1993 Q3 | 2.4 Million USD | -7.69% |
| 1993 Q4 | 1.6 Million USD | -33.33% |
| 1993 Q1 | 2.3 Million USD | -4.17% |
| 1993 FY | 8.9 Million USD | -5.32% |
| 1993 Q2 | 2.6 Million USD | 13.04% |
| 1992 FY | 9.4 Million USD | 17.5% |
| 1992 Q3 | 2.8 Million USD | 27.27% |
| 1992 Q1 | 2 Million USD | -13.04% |
| 1992 Q4 | 2.4 Million USD | -14.29% |
| 1992 Q2 | 2.2 Million USD | 10.0% |
| 1991 Q2 | 1.7 Million USD | 6.25% |
| 1991 FY | 8 Million USD | 33.33% |
| 1991 Q4 | 2.3 Million USD | 0.0% |
| 1991 Q3 | 2.3 Million USD | 35.29% |
| 1991 Q1 | 1.6 Million USD | -11.11% |
| 1990 Q3 | 1.8 Million USD | 20.0% |
| 1990 Q2 | 1.5 Million USD | 36.36% |
| 1990 Q1 | 1.1 Million USD | -26.67% |
| 1990 Q4 | 1.8 Million USD | 0.0% |
| 1990 FY | 6 Million USD | 53.85% |
| 1989 Q4 | 1.5 Million USD | 36.36% |
| 1989 Q2 | 700 Thousand USD | -81.58% |
| 1989 Q1 | 3.8 Million USD | 154.29% |
| 1989 Q3 | 1.1 Million USD | 57.14% |
| 1989 FY | 3.9 Million USD | 95.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 129.092% |
| AngioDynamics, Inc. | -97.71 Million USD | 117.169% |
| AtriCure, Inc. | -26.68 Million USD | 162.875% |
| Avinger, Inc. | -16.63 Million USD | 200.854% |
| Azenta, Inc. | -73.12 Million USD | 122.943% |
| BioLife Solutions, Inc. | -70.82 Million USD | 123.688% |
| The Cooper Companies, Inc. | 533.1 Million USD | 96.853% |
| Daxor Corporation | -177.07 Thousand USD | 9574.516% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 211.018% |
| Femasys Inc. | -14.5 Million USD | 215.636% |
| GlucoTrack, Inc. | -7.1 Million USD | 336.163% |
| Harvard Bioscience, Inc. | 1.89 Million USD | -785.797% |
| Hologic, Inc. | 882.6 Million USD | 98.099% |
| ICU Medical, Inc. | 22.82 Million USD | 26.497% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 99.05% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 263.36% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 54.757% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 343.126% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 343.126% |
| Masimo Corporation | 136.5 Million USD | 87.709% |
| Microbot Medical Inc. | -9.85 Million USD | 270.238% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | -14.324% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 86.464% |
| Nephros, Inc. | -1.59 Million USD | 1153.17% |
| NovoCure Limited | -232.87 Million USD | 107.204% |
| NEXGEL, Inc. | -3.47 Million USD | 582.514% |
| NEXGEL, Inc. | -3.47 Million USD | 582.514% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 116.32% |
| OraSure Technologies, Inc. | 54.07 Million USD | 68.977% |
| Pro-Dex, Inc. | 7.17 Million USD | -133.891% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 138.502% |
| Predictive Oncology Inc. | -13.92 Million USD | 220.513% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | 715.82% |
| QuidelOrtho Corporation | 139.1 Million USD | 87.939% |
| Repligen Corporation | 54.57 Million USD | 69.259% |
| Sanara MedTech Inc. | -4.21 Million USD | 498.016% |
| STAAR Surgical Company | 28.09 Million USD | 40.289% |
| Sharps Technology, Inc. | -10.12 Million USD | 265.672% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 119.738% |
| Jin Medical International Ltd. | 2.86 Million USD | -485.123% |